Gut microbiome-targeted therapies for Alzheimer’s disease
ABSTRACTThe advent of highthroughput ‘omics’ technologies has improved our knowledge of gut microbiome in human health and disease, including Alzheimer’s disease (AD), a neurodegenerative disorder. Frequent bidirectional communications and mutual regulation exist between the gastrointestinal tract...
Main Authors: | Tao Zhang, Guangqi Gao, Lai-Yu Kwok, Zhihong Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2023.2271613 |
Similar Items
-
Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target
by: Tao Zhang, et al.
Published: (2022-02-01) -
Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
by: Hang-Yu Li, et al.
Published: (2021-09-01) -
Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation
by: Karolina Kaźmierczak-Siedlecka, et al.
Published: (2021-09-01) -
Probiotics, Prebiotics, Synbiotics, and Fermented Foods as Potential Biotics in Nutrition Improving Health via Microbiome-Gut-Brain Axis
by: Divakar Dahiya, et al.
Published: (2022-06-01) -
Gut microbiome-targeted therapies in liver cirrhosis: a protocol for systematic review and meta-analysis
by: Honglin Jiang, et al.
Published: (2022-08-01)